5 commercial payer policies list 0041U. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
5 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 0041U |
|---|---|---|
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 0041U |
|---|---|---|
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 0041U |
|---|---|---|
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 0041U |
|---|---|---|
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 0041U |
|---|---|---|
| Investigational Gene Expression, Biomarker, and Multianalyte Testing | Sep 1, 2026 | Covered |